RETREG1 and hepatocellular carcinoma: Additionally, overexpression of FAM134B in HCC was significantly associated with tumor size, vascular invasion, differentiation grade, cancer recurrence, portal vein tumor thrombus, shorter overall survival, and shorter disease-free survival76.